These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 26058462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S.
    J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
    [Abstract] [Full Text] [Related]

  • 4. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW.
    Cancer Res; 2008 Mar 01; 68(5):1451-61. PubMed ID: 18316609
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H, Park YN.
    Dig Dis; 2014 Mar 01; 32(6):778-85. PubMed ID: 25376296
    [Abstract] [Full Text] [Related]

  • 6. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS, Noh SJ, Jang KY, Park HS, Chung MJ, Park CK, Moon WS.
    Int J Oncol; 2012 Dec 01; 41(6):2150-8. PubMed ID: 22993038
    [Abstract] [Full Text] [Related]

  • 7. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B, Cavard C, Perret C.
    J Hepatol; 2010 Feb 01; 52(2):280-1. PubMed ID: 20006402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.
    Shan YF, Huang YL, Xie YK, Tan YH, Chen BC, Zhou MT, Shi HQ, Yu ZP, Song QT, Zhang QY.
    Med Oncol; 2011 Dec 01; 28(4):1012-6. PubMed ID: 20571936
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular and histological correlations in liver cancer.
    Calderaro J, Ziol M, Paradis V, Zucman-Rossi J.
    J Hepatol; 2019 Sep 01; 71(3):616-630. PubMed ID: 31195064
    [Abstract] [Full Text] [Related]

  • 19. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN.
    Hepatology; 2011 Nov 01; 54(5):1707-17. PubMed ID: 22045674
    [Abstract] [Full Text] [Related]

  • 20. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
    Zen Y, Vara R, Portmann B, Hadzic N.
    Histopathology; 2014 Apr 01; 64(5):671-82. PubMed ID: 24138022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.